CRDF Q1 2026 Earnings EPS Miss as PreRevenue Biotech Advances Clinical Pipeline PM Q1 2026 Earnings EPS Beats Estimates by 414 Amidst Operational Challenges NREF Q1 2026 Earnings EPS Surpasses Estimates by Nearly 13 GLPG Q1 2026 Earnings Strong EPS Beat Amidst Flat Revenue Environment SE Q1 2026 Earnings EPS Misses Estimates Stock Dips Slightly DVS Q4 2025 Earnings Significant EPS Miss Amid Silver Exploration Challenges XENE Q1 2026 Earnings EPS Beat in PreRevenue Biotech Stock Edges Higher KRMD Q1 2026 Earnings Narrow EPS Beat Signals Steady Progress Amid Loss Reduction SENEB Q1 2026 Earnings Strong EPS of 619 Drives Stock Gain of 229